Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 10.73% | 61.50 | 0.0% | $1907.60m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 5.98% | 612.81 | 2.5% | $1175.40m | |
| GILD | Gilead Sciences, Inc. | 3.33% | 77.83 | 1.0% | $1168.63m | |
| AMGN | Amgen, Inc. | 2.49% | 229.70 | 1.3% | $672.54m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 3.81% | 287.96 | 1.9% | $606.67m | |
| NVAX | Novavax, Inc. | 2.68% | 46.04 | 102.0% | $590.02m | |
| BIIB | Biogen, Inc. | 2.19% | 307.09 | 1.6% | $417.42m | |
| ILMN | Illumina, Inc. | -2.67% | 363.05 | 3.5% | $387.48m | |
| SRNE | Sorrento Therapeutics, Inc. | 2.02% | 5.05 | 1.8% | $306.68m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 4.79% | 119.90 | 2.0% | $292.13m | |
| SGEN | Seattle Genetics, Inc. | 3.74% | 157.21 | 6.1% | $269.08m | |
| A | Agilent Technologies, Inc. | 1.67% | 88.14 | 1.6% | $202.48m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 0.90% | 106.55 | 4.3% | $186.35m | |
| CODX | Co-Diagnostics, Inc. | 3.03% | 18.00 | 0.0% | $173.36m | |
| INCY | Incyte Corp. | 1.35% | 101.91 | 2.5% | $166.15m |
Company Profile
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture and marketing of human therapeutics. Its products include the following brands: Aranesp, BLINCYTO, Corlanor, ENBREL, EPOGEN, IMLYGIC, KYPROLIS, Neulasta, NEUPOGEN, Nplate, Parsabiv, Prolia, Repatha, Sensipar, Vectibix, and XGEVA. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.